104 related articles for article (PubMed ID: 11000062)
21. Establishment of in-vitro models of chemotherapy resistance.
Watson MB; Lind MJ; Cawkwell L
Anticancer Drugs; 2007 Aug; 18(7):749-54. PubMed ID: 17581296
[TBL] [Abstract][Full Text] [Related]
22. Ligand-targeted therapeutics in anticancer therapy.
Allen TM
Nat Rev Cancer; 2002 Oct; 2(10):750-63. PubMed ID: 12360278
[TBL] [Abstract][Full Text] [Related]
23. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H; Wesseling J; Boezen HM; van der Graaf WT
Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
[TBL] [Abstract][Full Text] [Related]
24. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
25. Current concepts for chronochemotherapy of cancer.
Laerum OD; Smaaland R; Abrahamsen JF
J Infus Chemother; 1995; 5(3 Suppl 1):159-70. PubMed ID: 8528978
[TBL] [Abstract][Full Text] [Related]
26. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
27. [The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells].
Jiao SC; Huang J; Sun Y; Lu SX
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):195-7. PubMed ID: 12812659
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
29. The plateau in cytotoxic cancer drug discovery.
Hollander S; Gordon M
J Med; 1990; 21(3-4):143-63. PubMed ID: 2204674
[TBL] [Abstract][Full Text] [Related]
30. Rationale for the selection of chemotherapeutic agents.
Hryniuk WM; Bertino JR
Adv Intern Med; 1969; 15():267-97. PubMed ID: 4908621
[No Abstract] [Full Text] [Related]
31. [Mechanisms of action of drug therapy of cancer].
García G
Gac Med Mex; 1972 Feb; 103(2):129-45. PubMed ID: 5022797
[No Abstract] [Full Text] [Related]
32. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy.
Maeda H; Matsumura Y
Adv Drug Deliv Rev; 2011 Mar; 63(3):129-30. PubMed ID: 20457195
[No Abstract] [Full Text] [Related]
33. [Approaches to the enhancement of anticancer activity in cancer chemotherapy].
Wakui A
Hokkaido Igaku Zasshi; 1982 Jul; 57(4):399-405. PubMed ID: 7173811
[No Abstract] [Full Text] [Related]
34. [On the effect of a new adjuvant on the clinical course of cancer disease in man. II. Observations on the effect of an adjuvant medication in surgically incurable cancer cases].
Moser H
Krebsarzt; 1967; 22(4):219-21. PubMed ID: 5592993
[No Abstract] [Full Text] [Related]
35. [Modeling the processes of malignant growth and treatment].
Petrovskiĭ AM; Orkina EL; Sakharov MP; Sof'ina ZP; Merkulov MF
Farmakol Toksikol; 1975; 38(1):104-7. PubMed ID: 1112385
[No Abstract] [Full Text] [Related]
36. Dose matters: Direct killing or immunoregulatory effects of natural polysaccharides in cancer treatment.
Pang G; Wang F; Zhang LW
Carbohydr Polym; 2018 Sep; 195():243-256. PubMed ID: 29804974
[TBL] [Abstract][Full Text] [Related]
37. Modulation of chemotherapy antineoplastic agents with biologic agents: enhancement of antitumor activities by interleukin-1.
Johnson CS
Curr Opin Oncol; 1992 Dec; 4(6):1108-15. PubMed ID: 1457525
[TBL] [Abstract][Full Text] [Related]
38. [Indication for neoplasm chemotherapy and administration of antineoplastic agents].
Hiraki K; Kimura I
Naika; 1970 Jun; 25(6):1163-9. PubMed ID: 5431259
[No Abstract] [Full Text] [Related]
39. Some basic guidelines in the use of chemotherapy for patients with incurable malignancy.
Kearsley JH
Palliat Med; 1994; 8(1):11-7. PubMed ID: 7514067
[TBL] [Abstract][Full Text] [Related]
40. [Tissue culture and cancer chemotherapy].
Tanneberger S
Arch Geschwulstforsch; 1968; 31(4):387-400. PubMed ID: 4876253
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
